BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32799418)

  • 1. Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis.
    Miao S; Lu M; Liu Y; Shu D; Zhu Y; Song W; Ma Y; Ma R; Zhang B; Fang C; Ming ZY
    Mol Oncol; 2020 Oct; 14(10):2546-2559. PubMed ID: 32799418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The miR-561-5p/CX
    Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
    Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.
    Sun C; Hu A; Wang S; Tian B; Jiang L; Liang Y; Wang H; Dong J
    Int J Oncol; 2020 Jul; 57(1):249-263. PubMed ID: 32319605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of platelet with tumor cell aggravates hepatocellular carcinoma metastasis by activating TLR4/ADAM10/CX3CL1 axis.
    Gao JH; He AD; Liu LM; Zhou YJ; Guo YW; Lu M; Zeng XB; Gong X; Lu YJ; Liang HF; Zhang BX; Ma R; Zhang RY; Ming ZY
    Cancer Lett; 2024 Mar; 585():216674. PubMed ID: 38280480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CX3CL1/CX3CR1 axis is upregulated in chronic kidney disease and contributes to angiotensin II-induced migration of vascular smooth muscle cells.
    Li C; Zhong X; Xia W; He J; Gan H; Zhao H; Xia Y
    Microvasc Res; 2020 Nov; 132():104037. PubMed ID: 32615135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.
    Liu P; Liang Y; Jiang L; Wang H; Wang S; Dong J
    Int J Oncol; 2018 Oct; 53(4):1544-1556. PubMed ID: 30066854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
    Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
    Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CX3CR1/CX3CL1 Axis Mediates Platelet-Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis.
    Furio E; García-Fuster MJ; Redon J; Marques P; Ortega R; Sanz MJ; Piqueras L
    Thromb Haemost; 2018 Mar; 118(3):562-571. PubMed ID: 29433150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
    Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS
    Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
    Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
    Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus chemokine receptor US28 induces migration of cells on a CX3CL1-presenting surface.
    Hjortø GM; Kiilerich-Pedersen K; Selmeczi D; Kledal TN; Larsen NB
    J Gen Virol; 2013 May; 94(Pt 5):1111-1120. PubMed ID: 23303826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
    Zhang P; Wang BJ; Wang JZ; Xie XM; Tong QX
    Curr Med Sci; 2020 Dec; 40(6):1121-1127. PubMed ID: 33428140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
    Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
    BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
    Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
    Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
    Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
    J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
    Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways.
    Xie L; Dai H; Li M; Yang W; Yu G; Wang X; Wang P; Liu W; Hu X; Zhao M
    J Cell Mol Med; 2019 May; 23(5):3386-3401. PubMed ID: 30793486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.